Viewing Study NCT00304551


Ignite Creation Date: 2025-12-24 @ 11:50 PM
Ignite Modification Date: 2026-06-14 @ 7:32 PM
Study NCT ID: NCT00304551
Status: COMPLETED
Last Update Posted: 2010-06-03
First Post: 2006-03-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Peginterferon Alfa-2a in Combination With Ribavirin in Chronic Hepatitis C (CHC) Patients With Compensated Liver Cirrhosis (LC)
Sponsor: Chugai Pharmaceutical
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Liver Cirrhosis View
None Chronic Hepatitis C View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CHC with compensated LC View